BiotechTube
ndd Medical Technologies

ndd Medical Technologies

Zurich, Switzerland· Est.
nddmed.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $45M

Overview

ndd Medical Technologies is a well-established, privately-held Swiss medtech firm with over 30 years of experience in the respiratory diagnostics sector. The company has built a strong global reputation around its EasyOne product family, which includes portable spirometers and sophisticated lab-grade PFT systems featuring DLCO, lung volumes, and MBW capabilities. Its integrated software platform, EasyOne Connect, and AI-driven coaching tool 'Buddy' enhance usability and data management. Operating in a large and growing market driven by the global burden of COPD and asthma, ndd is positioned as a key player in enabling early diagnosis and improving patient outcomes through precise, user-friendly technology.

Respiratory

Technology Platform

Patented TrueFlow ultrasonic flowmeter technology for calibration-free, drift-resistant spirometry; Integrated EasyOne Connect software platform; AI-powered 'Buddy' spirometry coaching system.

Funding History

2
Total raised:$45M
Series B$30M
Series A$15M

Opportunities

The massive global burden of undiagnosed COPD and asthma creates a significant opportunity for expanded point-of-care spirometry adoption in primary care settings.
The shift towards value-based care and preventative medicine provides financial incentives for clinics to invest in in-house diagnostic testing.
Integration of AI and telehealth features opens new avenues for remote patient monitoring and decentralized clinical trials.

Risk Factors

Faces intense competition from larger, diversified medical device corporations with greater resources.
Growth is dependent on overcoming barriers to spirometry adoption in primary care, including reimbursement issues and operator training requirements.
Subject to regulatory and supply chain risks inherent to global medical device manufacturing and distribution.

Competitive Landscape

ndd competes in the pulmonary function testing market against several established players, including large medtech firms like Vyaire Medical and MGC Diagnostics, as well as specialized companies such as COSMED and Schiller. Its key competitive differentiators are its patented, calibration-free ultrasonic sensor technology, the portability and robustness of its devices, and its integrated software with AI coaching. The market is fragmented, with competition based on accuracy, reliability, ease of use, price, and clinical support.

More companies in Diagnostics & Precision Medicine →More companies in Switzerland →